Please assess the completion status of the following clinical trial:

Trial Title: Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~patients age 18 years or above undergoing elective total hip or knee replacement surgery~Exclusion criteria:~according to the label recommendation for Pradaxa 220 mg QD

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- patients after hip or knee replacement (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).